Authors:
VESLEMES M
POLYZOS A
LATSI P
DIMITROULIS J
STAMATIADIS D
DARDOUFAS C
RASIDAKIS A
KATSILAMBROS N
JORDANOGLOU J
Citation: M. Veslemes et al., OPTIMAL DURATION OF CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A RANDOMIZED STUDY OF 4 VERSUS 6 CYCLES OF CISPLATIN-ETOPOSIDE, Journal of chemotherapy, 10(2), 1998, pp. 136-140
Authors:
GENNATAS CS
PSYCHOGIOS J
DARDOUFAS C
TSAVARIS N
ATHANASIADIS S
Citation: Cs. Gennatas et al., 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 3RD-LINE ENDOCRINE THERAPY IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 702-702
Authors:
LIMOURIS GS
SHUKLA SK
CONDIPAPHITI A
GENNATAS C
KOUVARIS I
VITORATOS N
MANETOU A
DARDOUFAS C
RIGAS V
VLAHOS L
Citation: Gs. Limouris et al., PALLIATIVE THERAPY USING RHENIUM-186-HEDP IN PAINFUL BREAST OSSEOUS METASTASES, Anticancer research, 17(3B), 1997, pp. 1767-1772
Authors:
KOUVARIS J
PLATANIOTIS GA
SANDILOS P
DARDOUFAS C
DAMATOPOULOU A
VLAHOS L
PAPAVASILIOU C
Citation: J. Kouvaris et al., COMBINED TELETHERAPY AND INTRACAVITARY BRACHYTHERAPY BOOST FOR THE TREATMENT OF NASOPHARYNGEAL CARCINOMA, Radiotherapy and oncology, 38(3), 1996, pp. 263-267
Authors:
DARDOUFAS C
PLATANIOTIS GA
DAMATOPOULOU A
KOUVARIS J
VLAHOS L
Citation: C. Dardoufas et al., A CASE OF RADIATION MYELOPATHY AFTER 2X8.5 GY FOR INOPERABLE NON-SMALL-CELL LUNG-CANCER, European journal of cancer, 31A(13-14), 1995, pp. 2418-2419